3237. Preoperative evaluation of mediastinal lymph nodes in non-small cell lung cancer using [68Ga]FAPI-46 PET/CT: a prospective pilot study
Yeon-koo Kang, Kwon Joong Na, Jimyung Park, Nakwon Kwak, Yun-Sang Lee, Hongyoon Choi, Young Tae Kim
Eur J Nucl Med Mol Imaging. 2024 Mar 7;51(8):2409–2419.Link
3236. Effect of thyroid-stimulating hormone suppression on quality of life in thyroid lobectomy patients: interim analysis of a multicenter, randomized controlled trial in low- to intermediate-risk thyroid cancer patients (MASTER study)
Ja Kyung Lee, Eu Jeong Ku, Su-Jin Kim, Woochul Kim, Jae Won Cho, Kyong Yeun Jung, Hyeong Won Yu, Yea Eun Kang, Mijin Kim, Hee Kyung Kim, Junsun Ryu, June Young Choi; MASTER study group
3233. Global prevalence of Mycobacterium massiliense strains with recombinant rpoB genes (Rec-Mas) horizontally transferred from Mycobacterium abscessus: two major types, dominant circulating clone 7 and MLST ST46 sequence type
Dong Hyun Kim 1 2, Hyejun Seo 1 3 4, Sangkwon Jung 3, Bum-Joon Kim 1 2 3 4 5
Microbiol Spectr. 2024 Oct 21;12(12):e0193524.Link
3232. Predictive value of early dynamic changes of NLR and PLR for the efficacy of immune checkpoint inhibitor in head and neck squamous cell carcinoma
Dong Hyun Kim 1, Seo Yoon Jang 2, Bhumsuk Keam 3
Oral Surg Oral Med Oral Pathol Oral Radiol. 2024 Dec;138(6):763-771.Link
3231. Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH study
Dong Hyun Kim 1, Seung Taek Lim 2, Hye Ryun Kim 3, Eun Joo Kang 4, Hee Kyung Ahn 5, Yun-Gyoo Lee 6, Der Sheng Sun 7, Jung Hye Kwon 8, Sang-Cheol Lee 9, Hyun Woo Lee 10, Min Kyoung Kim 11, Bhumsuk Keam 12, Keon-Uk Park 13, Seong-Hoon Shin 14, Hwan Jung Yun 15
3230. Comparison of Tumor Microenvironments between Primary Tumors and Lymph Node Metastases in Head and Neck Squamous Cell Carcinoma and Their Predictive Role in Immune Checkpoint Inhibitor Treatment
3229. Changes in the tumor microenvironment in recurrent head and neck squamous cell carcinoma and its implication on efficacy of immune checkpoint inhibitors
3228. Analysis of Response and Progression Patterns of Tyrosine Kinase Inhibitors in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Post Hoc Analysis of Two KCSG Phase II Trials
Youjin Kim 1, Bhumsuk Keam 2 3, Eun Joo Kang 4, Jin-Soo Kim 5, Hye Ryun Kim 6, Keun-Wook Lee 7, Jung Hye Kwon 8, Kyoung Eun Lee 9, Yaewon Yang 10, Yoon Hee Choi 11, Min Kyoung Kim 12, Jun Ho Ji 13, Tak Yun 14, Moon Young Choi 15, Ki Hyeong Lee 10, Sung-Bae Kim 16, Myung-Ju Ahn 17